Results for tag: "Non Invasive Cancer Diagnosis"

The Non Invasive Cancer Diagnosis market is a subset of the Diagnostics industry, focused on the development of technologies and techniques to detect cancer without the need for invasive procedures. These techniques are used to detect cancer in its early stages, allowing for more effective treatment and improved patient outcomes. Non Invasive Cancer Diagnosis technologies include imaging techniques such as MRI, CT, and PET scans, as well as blood tests and other biomarker tests. These technologies are used to detect cancer cells, identify their location, and monitor their progression. Some companies in the Non Invasive Cancer Diagnosis market include GE Healthcare, Philips Healthcare, Siemens Healthineers, and Roche Diagnostics. Other companies include Abbott Laboratories, Becton Dickinson, and Cepheid. Show Less Read more